HALEOS LABS LIMITED Financial Ratios
HALEOSLABS · Healthcare · Current price ₹1,531
P/E ratio
26.7x
P/B ratio
2.0x
ROE
8.1%
ROCE
9.8%
Debt / Equity
0.52
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 26.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 8.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 9.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.52 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with HALEOS LABS LIMITED's latest numbers.
HALEOS LABS LIMITED profitability
HALEOS LABS LIMITED generates a return on equity of 8.1% and a return on capital employed of 9.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.52 and a P/E of 26.7x, HALEOS LABS LIMITED is moderately leveraged. Our overall business-quality score for the company is 3.8 / 10.
Understand the ratios
More on HALEOS LABS LIMITED
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.